Company / Assets per Share
Cullinan Therapeutics, Inc. Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$10.63
FY2024
5-year range
$10.63 / $14.66
FY2020-FY2024
Trend
-8.8%
vs FY2023
Sector context
#92 of 210
Health Care
What the data says
At $10.63, Cullinan Therapeutics, Inc.'s assets per share ranks #92 of 210 in the Health Care sector. Assets per Share has declined for 3 consecutive years, from $14.66 in FY2021 to $10.63 in FY2024.
Based on SEC 10-K filings.
10.63 in FY2024 with a 3-year CAGR of -10.2%.
Declined from $12.25 to $10.63 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 210 in Health CareTop 44% of 210This company $10.63 Sector average $353.19
▼
-97.0% below sector average
Key checks
Key Insights
- Cullinan Therapeutics, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2024, assets per share decreased 8.8% year-over-year.
- Ranks #92 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.63 | -8.8% |
| FY2023 | $11.65 | -4.9% |
| FY2022 | $12.25 | -16.4% |
| FY2021 | $14.66 | +35.7% |
| FY2020 | $10.80 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026